Clinical Trials
Phase 2 study of Brentuximab Vedotin with Pembrolizumab in subjects with metastatic solid tumors
Disease Type: Melanoma
A phase 2 study of brentuximab vedotin in combination with pembrolizumab in subjects with metastatic solid malignancies after progression on prior PD-1 inhibitor treatment
Locations
Alleghany , Blacksburg , Roanoke , Salem , Wytheville